Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

Josephine A. Mauskopf; Evelina Zimovetz; Stephen M. Beard; Evelina Zimovetz; Stephen M. Beard; P Hodgkins; M Bischof; Jo Mauskopf; J Setyawan

Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom

Zimovetz, E., Beard, S., Hodgkins, P., Bischof, M., Mauskopf, J., & Setyawan, J. (2013). Cost-Utility Analysis of Lisdexamfetamine in the Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in the United Kingdom. Value in Health, 16(7), A549-A549.

Copy citation